BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.31% |
| 2 | Financials | 6.96% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.97% |
| 5 | Industrials | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BMTC
2926
DELISTED
Bryn Mawr Bank Corp
BMTC
| $116K | ﹤0.01% |
3,164
-296
| -9% | -$10.6K |
|
|
NVEE
2927
DELISTED
NV5 Global
NVEE
| $115K | ﹤0.01% |
6,740
+2,064
| +44% | +$37.5K |
|
2928
Avantor
AVTR
$9.37B
| $115K | ﹤0.01% |
7,814
+7,550
| +2,860% | +$128K |
|
2929
Pacific Biosciences
PACB
$357M
| $115K | ﹤0.01% |
22,209
-919,422
| -98% | -$5.14M |
|
2930
Codexis
CDXS
$175M
| $114K | ﹤0.01% |
8,307
+2,205
| +36% | +$34.7K |
|
|
EB
2931
DELISTED
Eventbrite
EB
| $114K | ﹤0.01% |
6,427
+5,406
| +529% | +$94.8K |
|
|
LBAI
2932
DELISTED
Lakeland Bancorp Inc
LBAI
| $113K | ﹤0.01% |
7,336
+2,306
| +46% | +$35.9K |
|
2933
Atara Biotherapeutics
ATRA
$76.7M
| $113K | ﹤0.01% |
320
+118
| +58% | +$44K |
|
2934
ATN International
ATNI
$491M
| $113K | ﹤0.01% |
1,936
+282
| +17% | +$16.2K |
|
2935
Gorman-Rupp
GRC
$2.11B
| $113K | ﹤0.01% |
3,248
-20
| -0.6% | -$635 |
|
2936
Photronics
PLAB
$1.97B
| $113K | ﹤0.01% |
10,371
-3,267
| -24% | -$31.6K |
|
|
QUOT
2937
DELISTED
Quotient Technology Inc
QUOT
| $113K | ﹤0.01% |
14,402
+3,737
| +35% | +$33.8K |
|
|
SMC
2938
Summit Midstream
SMC
$480M
| $112K | ﹤0.01% |
1,540
-458
| -23% | -$42.1K |
|
2939
CALL
TSMC
TSM
$2.23T
| $112K | ﹤0.01% |
24
| – | – |
|
|
2940
PUT
TSMC
TSM
$2.23T
| $112K | ﹤0.01% |
24
| – | – |
|
2941
Cerus
CERS
$572M
| $111K | ﹤0.01% |
21,526
+6,428
| +43% | +$34.5K |
|
2942
Zumiez
ZUMZ
$319M
| $111K | ﹤0.01% |
3,498
+972
| +38% | +$25.6K |
|
2943
1st Source
SRCE
$2.13B
| $110K | ﹤0.01% |
2,416
-111
| -4% | -$5.04K |
|
|
SWCH
2944
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $110K | ﹤0.01% |
7,072
+3,232
| +84% | +$47.9K |
|
|
KBAL
2945
DELISTED
Kimball International
KBAL
| $110K | ﹤0.01% |
5,714
+1,250
| +28% | +$22.3K |
|
2946
Regis Corp
RGS
$70.1M
| $110K | ﹤0.01% |
272
-108
| -28% | -$38.8K |
|
|
NWLI
2947
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $110K | ﹤0.01% |
410
-58
| -12% | -$15.3K |
|
|
UBNK
2948
DELISTED
United Financial Bancorp, Inc.
UBNK
| $110K | ﹤0.01% |
8,063
-1,054
| -12% | -$14.2K |
|
|
NSTG
2949
DELISTED
NanoString Technologies, Inc.
NSTG
| $110K | ﹤0.01% |
5,088
+2,171
| +74% | +$57.6K |
|
2950
Center Bancorp
CNOB
$1.81B
| $110K | ﹤0.01% |
4,941
+1,567
| +46% | +$34K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.